Two Sigma Advisers
FRTX

Two Sigma Advisers’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Two Sigma Advisers’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,389
Closed -$97K – 2964
2021
Q4 		$97K Buy
9,389
+3,925
+72% +$70.5K ﹤0.01% 2414
2021
Q3 		$177K Buy
5,464
+1,935
+55% +$62.8K ﹤0.01% 2269
2021
Q2 		$151K Buy
3,529
+1,333
+61% +$54.8K ﹤0.01% 2307
2021
Q1 		$108K Buy
+2,196
New +$121K ﹤0.01% 2436
2016
Q2 		– Sell
-32
Closed -$39K – 2228
2016
Q1 		$39K Hold
32
– – ﹤0.01% 1997
2015
Q4 		$41K Sell
32
-2
-6% -$2.61K ﹤0.01% 1827
2015
Q3 		$52K Sell
34
-5
-13% -$9.65K ﹤0.01% 1761
2015
Q2 		$86K Buy
39
+23
+144% +$72.1K ﹤0.01% 1817
2015
Q1 		$47K Sell
16
-4
-20% -$12.8K ﹤0.01% 1822
2014
Q4 		$66K Sell
20
-3
-13% -$10.6K ﹤0.01% 2360
2014
Q3 		$79K Buy
23
+8
+53% +$31.1K ﹤0.01% 2228
2014
Q2 		$57K Buy
+15
New +$56.4K ﹤0.01% 2389
2014
Q1 		– Sell
-5
Closed -$17K – 2595
2013
Q4 		$17K Buy
+5
New +$18.9K ﹤0.01% 2252

Other funds holding FRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return

Two Sigma Advisers's FRTX Position: Q1 2022 in Review

Two Sigma Advisers sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2022, closing a stake of 9,389 shares — an estimated $97K sold.

Two Sigma Advisers first reported a position in FRTX in Q4 2013 and held it in 13 quarters. The position peaked at $177K in Q3 2021. 22 funds tracked by Wall St. Rank hold FRTX as of Q1 2022.

  • Two Sigma Advisers reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 9,389 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $97K.
  • Two Sigma Advisers first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 13 quarters.
  • Two Sigma Advisers's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $177K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.